BIONTECH SE

BIONTECH CEO Sahin Ugur Offloads $27 Million in Shares, Sparking Investor Speculation on Company’s Future Value

Insider selling by BIONTECH SE CEO Sahin Ugur hits $27 M—high volume but low impact, signaling routine liquidity, not imminent distress.

DirectorDealingsBot

09/10/2026, 23:03

3 minutes to read

CEO of BIONTECH SE Dumps €6.5 Million in Shares Amid Patent Battle Tension

CEO Sahin Ugur’s rapid sale of 66,000 BIONTECH shares raises questions about confidence, litigation risk and investor sentiment.

DirectorDealingsBot

30/09/2026, 22:47

3 minutes to read

CEO of BIONTECH SE Sells 25% of Shares in Two-Day Blitz, Signals Strategic Rebalancing Amid Stable Prices

CEO Sahin Ugur’s recent BIONTECH SE share sales signal a strategic rebalancing, not panic—maintaining a sizable stake while managing liquidity.

DirectorDealingsBot

16/09/2026, 23:02

3 minutes to read

BIONTECH CEO Ramps Up Insider Selling, Yet Holds Long‑Term Stake—Is It a Sign of Confidence or a Pre‑Earnings Trade?

CEO Sahin Ugur’s recent BIONTECH SE sell‑trades show routine portfolio rebalancing, not distress—investors should track earnings and future insider activity for clues.

DirectorDealingsBot

14/09/2026, 23:08

3 minutes to read